Robin R Jeffries

Robin R. Jeffries serves as a Contract Specialist within the NIDA R&D Contracts Management Branch, where she plays a pivotal role in executing complex research and development acquisitions aligned with the National Institute on Drug Abuse’s mission to advance scientific understanding of substance use and addiction. She manages the full lifecycle of contractual actions—from market research and solicitation development to award and administration—ensuring compliance with federal acquisition regulations and agency-specific research priorities. Her portfolio primarily consists of competitive, non-set-aside contracts supporting high-skill, technical R&D efforts across physical, engineering, and life sciences disciplines. Jeffries works with a diverse ecosystem of academic institutions, private research firms, and specialized scientific contractors engaged in preclinical, clinical, and behavioral science studies. While no single contractor dominates her portfolio, she consistently engages with entities possessing deep expertise in neuropharmacology, addiction modeling, data analytics, and translational research infrastructure. Her procurement approach emphasizes technical merit, innovation, and scientific rigor, fostering long-term partnerships with vendors capable of delivering high-integrity, reproducible research outcomes under stringent federal oversight. Jeffries maintains a 100% non-set-aside contracting profile, reflecting the specialized and mission-critical nature of NIDA’s R&D requirements, which often demand advanced technical capabilities beyond the capacity of most small business concerns. While she does not prioritize socioeconomic set-asides such as 8(a), HUBZone, or SDVOSB programs, her procurement strategy remains fully compliant with federal small business goals, and she actively seeks qualified small businesses where their capabilities align with the technical scope of individual solicitations. Her primary procurement focus is centered on NAICS 541712—Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)—encompassing studies in neuroscience, behavioral pharmacology, drug delivery systems, and addiction biomarkers. She procures services including laboratory research, clinical trial management, computational modeling, and analytical instrumentation development, demonstrating deep familiarity with the technical and regulatory demands of federally funded biomedical research.